0001225208-18-006211.txt : 20180315
0001225208-18-006211.hdr.sgml : 20180315
20180315160848
ACCESSION NUMBER: 0001225208-18-006211
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180314
FILED AS OF DATE: 20180315
DATE AS OF CHANGE: 20180315
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ballinger Kevin J.
CENTRAL INDEX KEY: 0001566080
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11083
FILM NUMBER: 18692435
MAIL ADDRESS:
STREET 1: C/O BOSTON SCIENTIFIC CORPORATION
STREET 2: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP
CENTRAL INDEX KEY: 0000885725
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042695240
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
BUSINESS PHONE: 508-683-4000
MAIL ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
4
1
doc4.xml
X0306
4
2018-03-14
0000885725
BOSTON SCIENTIFIC CORP
BSX
0001566080
Ballinger Kevin J.
300 BOSTON SCIENTIFIC WAY
MARLBOROUGH
MA
01752-1234
1
EVP & Pres, Interven Cardio
Common Stock
2018-03-14
4
M
0
9375.0000
6.2800
A
113954.0000
D
Common Stock
2018-03-14
4
S
0
9375.0000
28.3718
D
104579.0000
D
Common Stock
2018-03-14
4
S
0
33428.0000
28.3097
D
71151.0000
D
Stock Option (Right to Buy)
6.2800
2018-03-14
4
M
0
9375.0000
0.0000
D
2022-02-27
Common Stock
9375.0000
0.0000
D
The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $28.27 to $28.51, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $28.17 to $28.51, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Grant to the reporting person of an option to purchase a specified number of common stock vesting in four equal annual installments beginning on February 27, 2013, the first anniversary of the date of grant.
/s/ Vance R. Brown, Attorney-in-fact
2018-03-15